Last year, OrthoPediatrics Corp generated 166.30M USD for its biggest-performing segment, Trauma and Deformity. The U.S. made the largest contribution, accounting for 186.40M USD last year. For the latest quarter, OrthoPediatrics Corp reported the revenue of 52.63M USD for the period ending 2026-06-30, which came from the top-performing segment, Trauma and Deformity. U.S. contributed the highest revenue, at 54.79M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Trauma and Deformity

Scoliosis

Sports Medicine and Other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Trauma and Deformity

166.30M(70.36%)

145.13M(70.89%)

106.78M(71.79%)

85.06M(69.55%)

65.83M(67.14%)

47.68M(67.08%)

49.37M(68.05%)

39.70M(68.96%)

Scoliosis

66.05M(27.94%)

55.15M(26.94%)

37.93M(25.50%)

33.43M(27.34%)

28.05M(28.60%)

20.74M(29.18%)

21.48M(29.61%)

16.66M(28.95%)

Sports Medicine and Other

4.00M(1.69%)

4.45M(2.17%)

4.02M(2.70%)

3.81M(3.11%)

4.17M(4.26%)

2.66M(3.75%)

1.70M(2.34%)

1.20M(2.09%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

U.S.

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

U.S.

186.40M(78.87%)

161.16M(78.72%)

111.01M(74.64%)

92.42M(75.57%)

77.78M(79.33%)

62.97M(88.59%)

55.05M(75.88%)

43.46M(75.51%)

34.91M(76.52%)

28.84M(77.32%)

24.91M(80.34%)

18.42M(77.78%)

International

49.95M(21.13%)

43.56M(21.28%)

37.72M(25.36%)

29.87M(24.43%)

20.27M(20.67%)

8.11M(11.41%)

17.50M(24.12%)

14.10M(24.49%)

10.71M(23.48%)

8.46M(22.68%)

6.09M(19.66%)

5.26M(22.22%)